AAAAAA

   
Results: 1-10 |
Results: 10
APOLIPOPROTEIN AIV - OCCURRENCE IN PLASMA AFTER ORAL AND INTRAVENOUS FAT LOADS
Authors: SCHAEFER JR HACKLER R SCHWARZ S RICHTER G KAFFARNIK H MAISCH B STEINMETZ A
Citation: Jr. Schaefer et al., APOLIPOPROTEIN AIV - OCCURRENCE IN PLASMA AFTER ORAL AND INTRAVENOUS FAT LOADS, Atherosclerosis, 134(1-2), 1997, pp. 341-342
ALCOHOL, LIPID-METABOLISM AND CORONARY HE ART-DISEASE
Authors: SCHNEIDER J KAFFARNIK H STEINMETZ A
Citation: J. Schneider et al., ALCOHOL, LIPID-METABOLISM AND CORONARY HE ART-DISEASE, Herz, 21(4), 1996, pp. 217-226
MULTICENTER COMPARISON OF MICRONIZED FENOFIBRATE AND SIMVASTATIN IN PATIENTS WITH PRIMARY TYPE IIA OR IIB HYPERLIPOPROTEINEMIA
Authors: STEINMETZ A SCHWARTZ T HEHNKE U KAFFARNIK H
Citation: A. Steinmetz et al., MULTICENTER COMPARISON OF MICRONIZED FENOFIBRATE AND SIMVASTATIN IN PATIENTS WITH PRIMARY TYPE IIA OR IIB HYPERLIPOPROTEINEMIA, Journal of cardiovascular pharmacology, 27(4), 1996, pp. 563-570
ORAL CONTRACEPTIVE-INDUCED PANCREATITIS I N THE HYPERCHYLOMICRONEMIA SYNDROME
Authors: SCHAEFER JR STEINMETZ A DUGI K EHLENZ K WICHERT PV KAFFARNIK H
Citation: Jr. Schaefer et al., ORAL CONTRACEPTIVE-INDUCED PANCREATITIS I N THE HYPERCHYLOMICRONEMIA SYNDROME, Deutsche Medizinische Wochenschrift, 120(10), 1995, pp. 325-328
INFLUENCE OF SOMATOSTATIN TO BIOCHEMICAL PARAMETERS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM
Authors: HASSE C ZIELKE A BRUNS C KUNNEKE M EHLENZ K BACHEM MG HEY A KAFFARNIK H GRESSNER A ROTHMUND M
Citation: C. Hasse et al., INFLUENCE OF SOMATOSTATIN TO BIOCHEMICAL PARAMETERS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(6), 1995, pp. 391-397
LIPOPROTEIN(A) AND FIBRINOGEN IN RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
Authors: STEIN D SCHOEBEL FC HEINS M STEINMETZ A KAFFARNIK H UHLICH D LESCHKE M STRAUER BE
Citation: D. Stein et al., LIPOPROTEIN(A) AND FIBRINOGEN IN RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, Clinical hemorheology, 15(5), 1995, pp. 737-747
ADRENOMYELONEUROPATHY, A COMMON-CAUSE OF ADDISONS-DISEASE
Authors: SCHAFER JR EHLENZ K STEINMETZ A PILZ C HUNNEMAN DH BAERWALD C VONWICHERT P KAFFARNIK H
Citation: Jr. Schafer et al., ADRENOMYELONEUROPATHY, A COMMON-CAUSE OF ADDISONS-DISEASE, Deutsche Medizinische Wochenschrift, 119(10), 1994, pp. 327-331
INCREASED IN-VIVO PRODUCTION OF HDL AND APOA-I UNDER THE TREATMENT WITH HMG-COA REDUCTASE INHIBITOR PRAVASTATIN
Authors: SCHAEFER JR STEINMETZ A SCHWEER H STRACKE H SEYBERTH H KAFFARNIK H
Citation: Jr. Schaefer et al., INCREASED IN-VIVO PRODUCTION OF HDL AND APOA-I UNDER THE TREATMENT WITH HMG-COA REDUCTASE INHIBITOR PRAVASTATIN, Journal of the American College of Cardiology, 1994, pp. 10000216-10000216
THE INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON PLASMA-CONCENTRATIONS OF APOLIPOPROTEIN-B AND A-I DURING THE FIRST YEAR OF LIFE
Authors: HERRMANN W HANF S KAFFARNIK H MOTZNY S REISSNER J STEINMETZ A
Citation: W. Herrmann et al., THE INFLUENCE OF APOLIPOPROTEIN-E POLYMORPHISM ON PLASMA-CONCENTRATIONS OF APOLIPOPROTEIN-B AND A-I DURING THE FIRST YEAR OF LIFE, Pediatrics, 93(2), 1994, pp. 296-302
RAPID-DETERMINATION OF APOLIPOPROTEIN-E PHENOTYPES FROM WHOLE PLASMA BY AUTOMATED ISOELECTRIC-FOCUSING USING PHASTSYSTEM(TM) AND IMMUNOFIXATION
Authors: HACKLER R SCHAFER JR MOTZNY S BRAND S KLEINE TO KAFFARNIK H STEINMETZ A
Citation: R. Hackler et al., RAPID-DETERMINATION OF APOLIPOPROTEIN-E PHENOTYPES FROM WHOLE PLASMA BY AUTOMATED ISOELECTRIC-FOCUSING USING PHASTSYSTEM(TM) AND IMMUNOFIXATION, Journal of lipid research, 35(1), 1994, pp. 153-158
Risultati: 1-10 |